Selank Amidate Vial Size — Options & Storage Guide

The most common mistake researchers make with Selank Amidate isn't the dosing protocol. It's misunderstanding how vial size impacts reconstitution ratios, dosing precision, and peptide stability. A 5mg vial reconstituted with 2.5ml bacteriostatic water delivers a completely different concentration than the same volume added to a 10mg vial, and that difference compounds across every draw.

We've guided hundreds of research facilities through peptide procurement decisions. The gap between optimal storage and premature degradation comes down to three factors most suppliers never mention: vial size selection relative to study protocol, reconstitution volume calculations, and post-mixing stability windows that vary by concentration.

What vial sizes does Selank Amidate come in?

Selank Amidate vials are typically available in 5mg and 10mg lyophilised powder formats, with some research suppliers offering 2mg or custom batch sizes for specific study designs. The vial size you select determines your reconstitution concentration, which directly affects dosing precision and the number of administrations per vial. Larger vial sizes reduce per-dose cost but require careful calculation to maintain dosing accuracy across the study timeline.

Most researchers assume vial size is purely about quantity. It isn't. The Selank Amidate vial size you choose establishes your entire dosing infrastructure: syringe volume requirements, draw technique precision, and the practical limit of how many doses you can extract before peptide degradation becomes a variable. A 5mg vial reconstituted with 1ml bacteriostatic water yields 5,000mcg/ml. Far too concentrated for precise draws below 100mcg using standard insulin syringes. The same 5mg vial with 2.5ml yields 2,000mcg/ml, making 250mcg doses straightforward with 0.125ml draws. This article covers exactly how vial size determines reconstitution strategy, what storage protocols protect peptide integrity after mixing, and which vial size aligns with different research timelines.

Understanding Selank Amidate Peptide Composition and Vial Formats

Selank is a synthetic heptapeptide. Seven amino acids in the sequence Thr-Lys-Pro-Arg-Pro-Gly-Pro. Originally developed at the Institute of Molecular Genetics of the Russian Academy of Sciences as an anxiolytic and nootropic research compound. The Amidate formulation refers to peptide bonds stabilised through amidation at the C-terminus, a modification that significantly extends half-life by protecting the peptide from enzymatic degradation. Without this modification, the peptide would break down within minutes of administration; amidation extends functional stability to several hours in biological systems.

Selank Amidate is supplied as lyophilised powder. A freeze-dried solid that removes water content to prevent hydrolysis and bacterial growth during storage. Lyophilisation is the gold standard for peptide preservation because it arrests all moisture-dependent degradation pathways. The powder remains stable at -20°C for 24–36 months when sealed, compared to 28 days maximum for reconstituted peptide refrigerated at 2–8°C. This stability differential is why Selank Amidate vial size matters: larger vials make economic sense only if your study protocol can consume the entire reconstituted volume within the 28-day window.

Vial formats are typically 2ml or 3ml borosilicate glass with rubber stoppers and aluminium crimp seals. The vial itself doesn't determine peptide quantity. That's the lyophilised mass inside, stated in milligrams. A 5mg Selank Amidate vial contains 5,000 micrograms of peptide; a 10mg vial contains 10,000 micrograms. When you add bacteriostatic water, you're not diluting potency. You're creating a measurable concentration. If you add 2ml bacteriostatic water to a 5mg vial, the resulting concentration is 2.5mg/ml or 2,500mcg/ml. If you add 5ml to a 10mg vial, the concentration drops to 2mg/ml or 2,000mcg/ml. The Selank Amidate vial size you choose determines how much bacteriostatic water you'll add, which in turn determines dosing precision.

Our team has observed that facilities running multi-week protocols often default to 10mg vials assuming cost efficiency, but then reconstitute with insufficient volume, resulting in concentrations that require syringe draws below 0.05ml. A volume most insulin syringes can't measure reliably. The result isn't just dosing error; it's protocol inconsistency that compromises data integrity across study cohorts.

Reconstitution Volume and Concentration Calculations by Vial Size

Reconstitution is where vial size becomes a dosing infrastructure decision. The concentration you create determines three things: syringe volume per dose, the number of doses per vial, and peptide stability duration post-mixing. Selank Amidate is water-soluble, meaning reconstitution with bacteriostatic water is straightforward. But the math matters.

For a 5mg Selank Amidate vial, standard reconstitution volumes and resulting concentrations are: 1ml bacteriostatic water yields 5mg/ml (5,000mcg/ml), 2ml yields 2.5mg/ml (2,500mcg/ml), and 2.5ml yields 2mg/ml (2,000mcg/ml). If your target dose is 250mcg, the 2ml reconstitution requires a 0.1ml (100-unit) syringe draw. Manageable with a 0.5ml or 1ml insulin syringe. The 1ml reconstitution requires only 0.05ml (50 units), which sits at the lower precision threshold of most syringes and increases user error risk. The 2.5ml reconstitution requires 0.125ml, which is still within reliable measurement range but uses more vial volume per dose.

For a 10mg Selank Amidate vial, the math shifts: 2ml bacteriostatic water yields 5mg/ml (5,000mcg/ml), 4ml yields 2.5mg/ml (2,500mcg/ml), and 5ml yields 2mg/ml (2,000mcg/ml). A 250mcg dose from the 4ml reconstitution requires 0.1ml. Identical to the 5mg vial reconstituted with 2ml. This is the critical insight: vial size and reconstitution volume must be paired to produce a target concentration that matches your syringe precision and dose volume.

The stability implication: once reconstituted, Selank Amidate peptide remains stable for approximately 28 days when stored at 2–8°C. A 10mg vial reconstituted with 5ml provides 5,000mcg total peptide; if your protocol calls for 250mcg daily doses, that's 20 doses. Well within the 28-day window. But if your protocol requires only 100mcg daily, you'd extract 50 doses theoretically, except peptide degradation begins around day 28. The larger vial doesn't save money if half the peptide degrades unused. This is why research timelines dictate optimal Selank Amidate vial size.

Our experience with peptide reconstitution protocols across hundreds of research compounds shows that dosing consistency improves significantly when syringe draw volumes fall between 0.08ml and 0.25ml. Volumes below 0.05ml introduce measurement error; volumes above 0.3ml require larger syringes that sacrifice precision. Match your vial size and reconstitution volume to hit that range.

Selank Amidate Vial Size: Comparison and Selection Guide

Choosing between 5mg and 10mg Selank Amidate vials isn't about peptide quality. Both contain the same synthetic heptapeptide at identical purity. The decision hinges on study duration, dosing frequency, and cost efficiency relative to peptide waste.

| Vial Size | Recommended Reconstitution Volume | Resulting Concentration | Doses per Vial (250mcg protocol) | Cost Efficiency | Ideal Study Duration | Professional Assessment |
|—|—|—|—|—|—|
| 5mg | 2ml bacteriostatic water | 2.5mg/ml (2,500mcg/ml) | 20 doses | Moderate | 2–3 week protocols | Best for short-term studies or initial protocol validation. Minimal waste if study parameters change mid-course |
| 10mg | 4ml bacteriostatic water | 2.5mg/ml (2,500mcg/ml) | 40 doses | High | 4–6 week protocols | Optimal for established protocols with consistent dosing schedules. Cost per dose drops 20–30% but requires full consumption within 28 days |
| 10mg | 5ml bacteriostatic water | 2mg/ml (2,000mcg/ml) | 40 doses at 200mcg | High | Extended protocols with lower per-dose requirements | Ideal when protocol calls for doses below 200mcg. Larger reconstitution volume improves syringe measurement accuracy |

The 5mg Selank Amidate vial size is the default recommendation for research teams new to Selank protocols or running exploratory studies where dosing frequency may adjust. Wasting 2–3 doses at protocol conclusion costs less than discarding half a 10mg vial because reconstituted peptide crossed the 28-day stability threshold. For established protocols with fixed dosing schedules running 4+ weeks, the 10mg vial reduces per-dose cost without increasing waste. Provided your team can reliably consume 40 doses within 28 days post-reconstitution.

One nuance most suppliers omit: bacteriostatic water itself has a 28-day use window once the vial seal is punctured, independent of peptide stability. If you're reconstituting multiple vials across a study timeline, you'll need to track both the bacteriostatic water expiration and each peptide vial's reconstitution date. This is another argument for 5mg vials in sequential studies: smaller volume means fewer reconstitution events and simpler stability tracking.

Storage Protocols for Lyophilised and Reconstituted Selank Amidate

Peptide degradation isn't gradual. It's threshold-based. Selank Amidate remains stable until a temperature excursion, light exposure, or microbial contamination event triggers a cascade that denatures the peptide structure. Once that threshold is crossed, the peptide doesn't weaken; it stops working. This is why storage protocol matters more than vial size.

Lyophilised Selank Amidate (unreconstituted powder) must be stored at -20°C in a freezer, protected from light and moisture. The sealed vial can tolerate short-term ambient temperature during shipping. Most suppliers use insulated packaging with gel packs to maintain <8°C during 24–48 hour transit. But long-term storage above -10°C accelerates peptide degradation. A lyophilised vial stored at -20°C retains >95% purity for 24–36 months; the same vial stored at 4°C loses measurable potency within 6–8 months. If your freezer experiences freeze-thaw cycles (common in auto-defrost units), store vials in an insulated container within the freezer to buffer temperature fluctuations.

Once reconstituted with bacteriostatic water, Selank Amidate must be refrigerated at 2–8°C and used within 28 days. Bacteriostatic water contains 0.9% benzyl alcohol, which inhibits bacterial growth but does not prevent peptide hydrolysis or oxidation. Both of which occur faster in aqueous solution than in lyophilised form. After 28 days, peptide concentration begins to drop measurably even under refrigeration. Studies on similar heptapeptides show 10–15% potency loss by day 35 and 25–30% loss by day 45 when stored at 4°C. Freezing reconstituted peptide halts hydrolysis but introduces a different risk: ice crystal formation can physically disrupt peptide structure, especially during slow freeze-thaw cycles. If you must freeze reconstituted Selank Amidate, use a -80°C ultra-low freezer and thaw only once.

The biggest storage mistake we see: researchers reconstitute a 10mg Selank Amidate vial with 2ml bacteriostatic water at protocol start, then leave the vial at room temperature during dosing sessions because frequent refrigerator access is inconvenient. A single 2-hour temperature excursion above 15°C accelerates degradation enough to compromise doses drawn in week 3–4. The correct approach: draw your daily or weekly doses into individual syringes, cap them, and refrigerate those syringes. Leaving the primary vial refrigerated continuously. Syringes capped with Luer-lock caps maintain sterility for 5–7 days under refrigeration, allowing batch preparation without exposing the main vial to repeated temperature swings.

Our peptide storage protocols specify that every reconstituted vial receive a handwritten label with reconstitution date, concentration, and expiration date (reconstitution date + 28 days). This eliminates the single most common source of protocol deviation: using peptide past its stability window because reconstitution date wasn't tracked.

Selank Amidate Vial Size: Practical Comparison

What If: Selank Amidate Vial Size Scenarios

What If You Reconstitute a 10mg Vial But Your Study Protocol Only Requires 15 Doses?

Freeze the unused portion immediately after your final dose is drawn. Use a sterile syringe to transfer the remaining solution into a cryovial or the original sealed vial, label it with reconstitution date and concentration, and store at -20°C or colder. Frozen reconstituted Selank Amidate retains 85–90% potency if thawed only once, compared to 60–70% potency if left refrigerated past day 28. The freeze-thaw process introduces minor peptide aggregation risk, but that's preferable to guaranteed hydrolytic degradation. If your freezer cycles above -10°C (common in frost-free units), the stability benefit diminishes. In that case, smaller vial sizes are the better procurement decision.

What If Your Bacteriostatic Water Runs Out Mid-Reconstitution?

Do not substitute sterile water, saline, or any other solvent. Bacteriostatic water contains 0.9% benzyl alcohol specifically to inhibit bacterial growth in multi-dose vials; without it, bacterial contamination becomes a variable in every subsequent draw. If you're mid-reconstitution and short on volume, add what bacteriostatic water remains, calculate the resulting concentration, and order more bacteriostatic water before the next reconstitution event. Our peptide reconstitution supplies include bacteriostatic water in 10ml and 30ml vials. The 30ml format provides enough volume for 6–8 reconstitution events and eliminates mid-study supply gaps.

What If You Need to Transport Reconstituted Selank Amidate Between Facilities?

Use a validated cold chain container that maintains 2–8°C for the entire transport duration. Gel pack coolers are insufficient for transport longer than 4 hours because they cannot maintain stable sub-8°C temperatures without active monitoring. Purpose-built peptide transport containers with temperature data loggers are available from laboratory suppliers and provide documented proof that cold chain was maintained. Critical for study protocol validation. If transport exceeds 6 hours or crosses temperature zones above 25°C ambient, freeze the peptide at -20°C before transport and use dry ice to maintain frozen state. Thaw upon arrival and use within 7 days; do not refreeze.

What If the Lyophilised Powder Looks Discoloured or Clumped Before Reconstitution?

Discard the vial. Lyophilised Selank Amidate should appear as a white to off-white powder, uniform in texture, with no yellowing, browning, or aggregated clumps. Discolouration indicates oxidative degradation or moisture infiltration; clumping suggests the vial seal was compromised during storage or shipping. Reconstituting degraded peptide doesn't salvage it. The peptide structure is already compromised. This is why supplier selection matters: peptide sourced from facilities without validated cold chain logistics introduces variables that no storage protocol can correct post-delivery.

The Honest Truth About Selank Amidate Vial Size

Let's be direct about this: vial size is a procurement decision, not a research variable. But it becomes a variable the moment you choose wrong. The 10mg Selank Amidate vial size doesn't deliver higher purity, better stability, or improved outcomes. It delivers cost efficiency, and that efficiency only materialises if your study timeline, dosing frequency, and team discipline align to consume the peptide within 28 days post-reconstitution. If those factors don't align, the 10mg vial becomes expensive waste.

The supplement industry has convinced researchers that